Related references
Note: Only part of the references are listed.White rice consumption and risk of type 2 diabetes: meta-analysis and systematic review
Emily A. Hu et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Chemical Constituents, Dietary Fiber, and γ-Oryzanol in Six Commercial Varieties of Brown Rice from Taiwan
Ting-Jang Lu et al.
CEREAL CHEMISTRY (2011)
Nutrients, composition of tocotrienols, tocopherols, and -oryzanol, and antioxidant activity in brown rice before and after biotransformation Nutrientes, composicion de tocotrienoles, tocoferoles y -oryzanol, y actividad antioxidante del arroz integral antes y despues de la biotransformacion
A. Jayadeep et al.
CYTA-JOURNAL OF FOOD (2011)
White Rice, Brown Rice, and Risk of Type 2 Diabetes in US Men and Women
Qi Sun et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Substituting Brown Rice for White Rice to Lower Diabetes Risk: A Focus-Group Study in Chinese Adults
Geng Zhang et al.
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION (2010)
Inhibition and induction of human cytochrome P450 enzymes: current status
Olavi Pelkonen et al.
ARCHIVES OF TOXICOLOGY (2008)
Characterization of cytochrome P450 protein expression along the entire length of the intestine of male and female rats
Doreen Mitschke et al.
DRUG METABOLISM AND DISPOSITION (2008)
Content of γ-oryzanol and composition of steryl ferulates in brown rice (Oryza sativa L.) of European origin
Andreas Miller et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2006)
Blood glucose lowering effects of brown rice in normal and diabetic subjects
Leonora N. Panlasigui et al.
INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION (2006)
Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening
K Srinivasan et al.
PHARMACOLOGICAL RESEARCH (2005)
Type 2 diabetes: principles of pathogenesis and therapy
M Stumvoll et al.
LANCET (2005)
Induction of phase I, II and III drug metabolism/transport by xenobiotics
CJ Xu et al.
ARCHIVES OF PHARMACAL RESEARCH (2005)
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity
M Ingelman-Sundberg
PHARMACOGENOMICS JOURNAL (2005)
57 varieties: the human cytochromes P450
DFV Lewis
PHARMACOGENOMICS (2004)
Low-glycemic index diets in the management of diabetes
J Brand-Miller et al.
DIABETES CARE (2003)
Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans
ZQ Wang et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Tolbutamide, flurbiprofen, and losartan as probes of CYP2C9 activity in humans
CR Lee et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Glycemic index: overview of implications in health and disease
DJA Jenkins et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2002)
Phenytoin metabolic ratio:: a putative marker of CYP2C9 activity in vivo
Y Caraco et al.
PHARMACOGENETICS (2001)
Diet and risk of Type II diabetes: the role of types of fat and carbohydrate
FB Hu et al.
DIABETOLOGIA (2001)
Different expression of hepatic and renal cytochrome P450s between the streptozotocin-induced diabetic mouse and rat
T Sakuma et al.
XENOBIOTICA (2001)
Share Paper
